Press Release: Trillium : Trillium Securityholders Approve Acquisition by Pfizer
CAMBRIDGE, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (Trillium or the Company) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment...
Read full article »
Trillium is a Massachusetts-based biopharmaceutical company that develops and commercializes immunotherapies for the treatment of cancer.
Read more